| | |
| Clinical data | |
|---|---|
| Other names | 2C-B-2-ETO; 4-Bromo-5-ethoxy-2-methoxyphenethylamine; 2-Methoxy-4-bromo-5-ethoxyphenethylamine |
| Routes of administration | Oral [1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 3–6 hours [1] |
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C11H16BrNO2 |
| Molar mass | 274.158 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2CB-2-EtO, also known as 4-bromo-2-methoxy-5-ethoxyphenethylamine, is a psychedelic drug of the phenethylamine, 2C, and TWEETIO families related to 2C-B. [1] [2] [3] [4] It is the derivative of 2C-B in which the methoxy group at the 2 position has been replaced with an ethoxy group. [1] [2] [3] [4] According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, 2CB-2-ETO produces maximal effects at a dose of about 15 mg orally. [1] [3] [4] Higher doses of 30 to 50 mg orally did not increase its effects any further but only prolonged their duration, from about 3 hours to perhaps 6 hours. [1] [3] [4] 2CB-2-ETO was said to have not had an intensity that resembled that of 2C-B at any dose. [1] It was also said to be dramatically or about 5-fold less potent than 2C-B. [2] The chemical synthesis of 2CB-2-ETO has been described. [1] The drug was first described in the literature by Shulgin in PiHKAL in 1991. [1] It was developed and tested by Darrell Lemaire, with publication via personal communication with Shulgin. [3] [5] [6] [7] [8]
The two tweetio analogs (2-ethoxy and 5-ethoxy) of both 2C-D and 2C-B have been explored and have dramatically reduced activity. The 5-tweetio (5-ethoxy) compounds are of twofold lessened potency, and the 2-tweetio (2-ethoxy) materials are down by another factor of five. The bis-etios (2,5-diethoxy homologs of 2C-D and 2C-B) are not known to be active at all.